Lv1
100 积分 2023-04-10 加入
TRIM37 controls cancer-specific vulnerability to PLK4 inhibition
2天前
已完结
Treating cancer with selective CDK4/6 inhibitors
18天前
已完结
Recent Advances in the Development of HIPK2 Inhibitors As anti-renal Fibrosis Agents
24天前
已完结
Loss of Kif18A Results in Spindle Assembly Checkpoint Activation at Microtubule-Attached Kinetochores
1个月前
已完结
Chromosomally unstable tumor cells specifically require KIF18A for proliferation
1个月前
已完结
Kinesins and cancer
1个月前
已完结
Targeting androgen biosynthesis in prostate cancer: implications on endocrine physiology
2个月前
已完结
Resistance to second-generation androgen receptor antagonists in prostate cancer
2个月前
已完结
CDK4/6 inhibitors in breast cancer: differences in toxicity profiles and impact on agent choice. A systematic review and meta-analysis
3个月前
已完结
Androgen receptor-dependent mechanisms mediating therapy resistance in prostate cancer
3个月前
已完结
皖公网安备34019202002308
